Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice

BACKGROUND: Diastolic dysfunction (DD), a hallmark of obesity and primary defect in heart failure with preserved ejection fraction, is a predictor of future cardiovascular events. We previously reported that linagliptin, a dipeptidyl peptidase-4 inhibitor, improved DD in Zucker Obese rats, a genetic...

詳細記述

保存先:
書誌詳細
出版年:Cardiovasc Diabetol
主要な著者: Aroor, Annayya R., Habibi, Javad, Kandikattu, Hemanth Kumar, Garro-Kacher, Mona, Barron, Brady, Chen, Dongqing, Hayden, Melvin R., Whaley-Connell, Adam, Bender, Shawn B., Klein, Thomas, Padilla, Jaume, Sowers, James R., Chandrasekar, Bysani, DeMarco, Vincent G.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5420102/
https://ncbi.nlm.nih.gov/pubmed/28476142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0544-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料